Inhibitory effect of anti-diabetic agents on rat organic anion transporter rOAT1

Yuichi Uwai, Hideyuki Saito, Yukiya Hashimoto, Ken Ichi Inui

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

The interactions of sulfonylureas and a novel anti-diabetic drug, nateglinide, with rat renal organic anion transporter (rOAT1) expressed in Xenopus laevis oocytes were studied. Uptake of p-aminohippurate via rOAT1 was markedly inhibited by glibenclamide and nateglinide, and moderately by chlorpropamide and tolbutamide. The inhibition constant values (K(i)) for chlorpropamide, glibenclamide, tolbutamide and nateglinide were 39.5, 1.6, 55.5 and 9.2 μM, respectively. Kinetic analysis showed that the inhibition of p-aminohippurate uptake by glibenclamide was competitive. Sulfonylureas examined and nateglinide did not show a trans-stimulation effect on [14C]p-aminohippurate efflux from rOAT1-expressing oocytes. There was no stimulation of [3H]glibenclamide uptake via rOAT1. These findings suggested that sulfonylureas and nateglinide interact with rOAT1, but these drugs are not translocated via the transporter. Copyright (C) 2000 Elsevier Science B.V.

Original languageEnglish
Pages (from-to)193-197
Number of pages5
JournalEuropean Journal of Pharmacology
Volume398
Issue number2
DOIs
StatePublished - 2000/06/16

Keywords

  • Nateglinide
  • OAT1 (organic anion transporter 1)
  • Renal tubular secretion
  • Sulfonylurea
  • Xenopus oocytes
  • p-Aminohippurate

ASJC Scopus subject areas

  • Pharmacology

Fingerprint

Dive into the research topics of 'Inhibitory effect of anti-diabetic agents on rat organic anion transporter rOAT1'. Together they form a unique fingerprint.

Cite this